6121 related articles for article (PubMed ID: 3500778)
1. Monoclonal antibodies detecting plasminogen activators on the membrane of leukemic lymphoid cells of T-cell origin.
Stünkel KG; Thiel E; Opitz HG; Schlumberger HD; Opitz U; Catovsky D; Klimetzek V
Cancer Detect Prev Suppl; 1987; 1():269-77. PubMed ID: 3500778
[TBL] [Abstract][Full Text] [Related]
2. Characterization of two monoclonal antibodies against human tissue-type plasminogen activator.
Schleef RR; Sinha M; Loskutoff DJ
Thromb Haemost; 1985 Apr; 53(2):170-5. PubMed ID: 4040658
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
[TBL] [Abstract][Full Text] [Related]
5. [Use of monoclonal antibodies in the diagnosis of fibrinolysis].
Wojta J; Korninger C; Kirchheimer J; Hattey E; Turcu L; Binder BR
Wien Klin Wochenschr; 1985 Mar; 97(5):244-8. PubMed ID: 4039506
[TBL] [Abstract][Full Text] [Related]
6. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
[TBL] [Abstract][Full Text] [Related]
7. Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells.
Jardí M; Inglés-Esteve J; Burgal M; Azqueta C; Velasco F; López-Pedrera C; Miles LA; Félez J
Thromb Haemost; 1996 Dec; 76(6):1009-19. PubMed ID: 8972026
[TBL] [Abstract][Full Text] [Related]
8. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
10. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
Ball ED; Graziano RF; Fanger MW
J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
[TBL] [Abstract][Full Text] [Related]
11. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
Ball ED; Kadushin JM; Schacter B; Fanger MW
J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
[TBL] [Abstract][Full Text] [Related]
12. Binding of monoclonal antibodies that inhibit spleen colony formation to leukemic cell lines.
Ralph SJ; McCaffery P; Tan AS; Berridge MV
Cancer Res; 1984 Sep; 44(9):3825-30. PubMed ID: 6744299
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody (WI-2) reactive against human transformed and leukemic cells.
Aota F; Chang D; Hill NO; Khan A
Jpn J Clin Oncol; 1984 Dec; 14(4):575-84. PubMed ID: 6520969
[TBL] [Abstract][Full Text] [Related]
14. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
Baryshnikov AIu
Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
[TBL] [Abstract][Full Text] [Related]
15. Production of plasminogen activator in a melanoma cell line.
Matsuo O; Sakai T; Matsuo C; Nishida Y; Akazawa K; Mihara H
Acta Physiol Lat Am; 1983; 33(4):305-13. PubMed ID: 6377823
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.
Haynes BF; Hemler M; Cotner T; Mann DL; Eisenbarth GS; Strominger JL; Fauci AS
J Immunol; 1981 Jul; 127(1):347-51. PubMed ID: 6787129
[TBL] [Abstract][Full Text] [Related]
17. Unique proliferation-associated marker expressed on activated and transformed human cells defined by monoclonal antibody.
Dubey DP; Staunton DE; Parekh AC; Schwarting GA; Antoniou D; Lazarus H; Yunis EJ
J Natl Cancer Inst; 1987 Feb; 78(2):203-12. PubMed ID: 3543453
[TBL] [Abstract][Full Text] [Related]
18. A monoclonal antibody detecting a 39,000 m.w. molecule that is present on B lymphocytes and chronic lymphocytic leukemia cells but is rare on acute lymphocytic leukemia blasts.
Zipf TF; Lauzon GJ; Longenecker BM
J Immunol; 1983 Dec; 131(6):3064-72. PubMed ID: 6358359
[TBL] [Abstract][Full Text] [Related]
19. Distribution of a new B-cell-associated surface antigen (BL7) detected by a monoclonal antibody in human leukemic disorders.
Al-Katib A; Wang CY; Koziner B
Cancer Res; 1985 Jul; 45(7):3058-63. PubMed ID: 3924396
[TBL] [Abstract][Full Text] [Related]
20. Expression of common acute lymphoblastic leukemia antigen (CALLA) on human malignant melanoma cell lines.
Carrel S; Schmidt-Kessen A; Mach JP; Heumann D; Girardet C
J Immunol; 1983 May; 130(5):2456-60. PubMed ID: 6339629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
